Status:
UNKNOWN
The Initial Management in Patients With Differentiated Thyroid Cancer in the Real World in China
Lead Sponsor:
Huazhong University of Science and Technology
Collaborating Sponsors:
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
West China Hospital
Conditions:
Differentiated Thyroid Cancer
Eligibility:
All Genders
Brief Summary
* To find out the gap between real-world clinical practice and guideline recommendations in initial management of DTC patients * To observe the characteristics of patients who achieved and did not ach...
Detailed Description
The DTCC 2nd will follow DTCC 1st and observe the long-term efficacy of initial management including surgery treatment, 131I therapy and TSH suppression therapy. It will involve nine hospitals which h...
Eligibility Criteria
Inclusion
- \- Patients who had been recruited into DTCC 1st study will be enrolled.
Exclusion
- Other malignant tumors;
- Severe organ damage such as heart failure of New York Heart Association classes III-IV, liver failure, respiratory failure, renal failure, etc.;
- Medical or psychological condition that would not permit the patient to complete the study or sign the informed consent; ④ Legal incapacity or limited legal capacity; ⑤ Unwilling to be followed up
Key Trial Info
Start Date :
December 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 28 2023
Estimated Enrollment :
1400 Patients enrolled
Trial Details
Trial ID
NCT04857086
Start Date
December 30 2020
End Date
March 28 2023
Last Update
April 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China